Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;34(1):e4732.
doi: 10.1002/bmc.4732.

A review of the bioanalytical methods for the quantitative determination of capecitabine and its metabolites in biological matrices

Jonathan E Knikman  1 , Hilde Rosing  2 , Henk-Jan Guchelaar  3 , A Cats  4 , Jos H Beijnen  1   2   5
Affiliations
Review

A review of the bioanalytical methods for the quantitative determination of capecitabine and its metabolites in biological matrices

Jonathan E Knikman et al. Biomed Chromatogr. 2020 Jan.

Abstract

The bioanalysis of the oral anticancer drug capecitabine and its metabolites has been investigated extensively over the past years. This paper reviews methods for the bioanalysis of capecitabine and its metabolites. The focus of this review will be on sample pre-treatment, chromatography and detection. Furthermore, the choice of standards and analytical problems encountered during analysis of capecitabine and its metabolites in biological matrices will be discussed. The major challenges in the bioanalysis of capecitabine and its metabolites are the simultaneous extraction and analysis due to the differences in polarity of the analytes. Furthermore we evaluate currently described methods for the quantification of capecitabine and its metabolites. Future wishes and perspectives are stated that could serve as an inspiration for further development of assays for the quantification of capecitabine and its metabolites.

Keywords: Fluoropyrimidines; bioanalysis; capecitabine; chromatography; mass spectrometry.

PubMed Disclaimer

References

REFERENCES

    1. Benet, L. Z., Broccatelli, F., & Oprea, T. I. (2011). BDDCS Applied to Over 900 Drugs. The AAPS Journal, 13(4), 519-547. https://doi.org/10.1208/s12248-011-9290-9
    1. Buchner, P., Mihola, E. V. A., Sahmanovic, A., Steininger, T., Dittrich, C., & Czejka, M. (2013). Validation of a Simple Assay for the Quantification of the Capecitabine Metabolites 5 ’- DFCR and 5’- DFUR for Drug Monitoring in Patients Receiving Outpatient Chemotherapy. 886, 881-886.
    1. Deenen, M. J., Rosing, H., Hillebrand, M. J., Schellens, J. H. M., & Beijnen, J. H. (2013). Quantitative determination of capecitabine and its six metabolites in human plasma using liquid chromatography coupled to electrospray tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 913-914, 30-40. https://doi.org/10.1016/j.jchromb.2012.11.033
    1. Deng, P., Ji, C., Dai, X., Zhong, D., Ding, L., & Chen, X. (2015). Simultaneous determination of capecitabine and its three nucleoside metabolites in human plasma by high performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 989, 71-79. https://doi.org/10.1016/j.jchromb.2015.03.002
    1. Derissen, E. J. B., Hillebrand, M. J. X., Rosing, H., Schellens, J. H. M., & Beijnen, J. H. (2015). Development of an LC-MS/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil. Journal of Pharmaceutical and Biomedical Analysis, 110, 58-66. https://doi.org/10.1016/j.jpba.2015.02.051

LinkOut - more resources